Citation Impact
Citing Papers
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Monitoring Sedation Status Over Time in ICU Patients
2003 Standout
Evaluation of Opioid Modulation in Major Depressive Disorder
2014
Pain Intensity on the First Day after Surgery
2013 Standout
Major depressive disorder
2016 Standout
Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans
1999
Caffeinated energy drinks—A growing problem
2008 Standout
Ephedrine Pharmacokinetics After the Ingestion of Nutritional Supplements Containing Ephedra sinica (ma huang)
1998
Occurrence, fate and transformation of emerging contaminants in water: An overarching review of the field
2017
Depression Is a Risk Factor for Noncompliance With Medical Treatment
2000 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
2000
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
2011
Analgesics in Patients with Hepatic Impairment
2012
The Therapeutic Use of Analgesics in Patients with Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations
2014
1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial
2003
Characterisation of pentamidine-resistant Trypanosoma brucei brucei
1995
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product
2022 Standout
Methods of measuring skin blood flow
1989
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Loneliness Matters: A Theoretical and Empirical Review of Consequences and Mechanisms
2010 Standout
Anesthesiology
1997 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers
2007
The Use of Stimulants to Modify Performance During Sleep Loss: A Review by the Sleep Deprivation and Stimulant Task Force of the American Academy of Sleep Medicine
2005
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation
2005
Metabolism of theophylline by cDNA‐expressed human cytochromes P‐450.
1995
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites†
2005
Pharmacokinetics of Opioids in Liver Disease
1999
The Pharmacokinetics of Vecuronium in Male and Female Patients
1998
Sedation, Analgesia, and Paralysis in the Intensive Care Unit
1993
Benefits and risks of furosemide in acute kidney injury
2010
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Oncogenes and signal transduction
1991 Standout
Antitrypanosomal activity of some pregnane glycosides isolated from Caralluma species
2009 StandoutNobel
Pain and Its Treatment in Outpatients with Metastatic Cancer
1994 Standout
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Drug glucuronidation in humans
1991
Clinical Pharmacology of Tramadol
2004 Standout
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
2010
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence
2004
Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method
1998
Herb-Drug Interactions
2005 Standout
Persistent Paralysis in Critically Ill Patients after Long-Term Administration of Vecuronium
1992
Does altered glucocorticoid homeostasis increase cardiovascular risk?
2004
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase
2003 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS
1990
Risk factors for the development of polyneuropathy and myopathy in critically ill patients
2001
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
Double-blind randomized trial of buprenorphine and methadone in opiate dependence
2001
Opioid Equianalgesic Tables: Are They All Equally Dangerous?
2009
Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing
2004
Pharmacology of Drugs for Hyperuricemia
2004
Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
2005
The Treatment of Human African Trypanosomiasis
1994
Modeling and comparison of dissolution profiles
2001 Standout
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation
2016 StandoutNobel
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Understanding the Dose-Effect Relationship
1981
Copper Active Sites in Biology
2014 Standout
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
1989 Nobel
Plasma catecholamine and corticosterone as well as brain catecholamine changes during coping in rats exposed to stressful footshock
1983
Ketoprofen: A Review of Its Pharmacologic and Clinical Properties
1986
The Use and Misuse of New Antibiotics
1995
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
2000
Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use: The Adverse Childhood Experiences Study
2003 Standout
Biological Feedbacks in Global Desertification
1990 StandoutScience
In vitro and in vivo evaluation of delayed-release behavior of diltiazem from its O-carboxymethyl-O-ethyl-β-cyclodextrin complex
1993
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure
1998
The Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in the Elderly
1987
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Production of high-titer helper-free retroviruses by transient transfection.
1993 StandoutNobel
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
2003
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Structure and Inhibition of Human Diamine Oxidase
2009
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Recreational drug misuse: issues for the cardiologist
2000
A randomized controlled clinical trial of pharmacokinetic theophylline dosing.
1986
Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
2007
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
1998
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Pharmacologic treatments for opioid dependence: detoxification and maintenance options
2007
Pain characteristics and treatment in an outpatient cancer population
1986
Effects of Sho-saiko-to on the Pharmacokinetics and Pharmacodynamics of Tolbutamide in Rats
1998
Works of Robert A. Upton being referenced
Methamphetamine and ethanol interactions in humans*
1995
Pharmacokinetics and Subjective Effects of Sublingual Buprenorphine, Alone or in Combination with Naloxone
2004
Pentamidine Pharmacokinetics in Patients with AIDS with Impaired Renal Function
1987
Bioavailability of Sublingual Buprenorphine
1997
Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine
2000
Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone
2003
Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations
1999
Pharmacokinetic Interactions Between Theophylline and Other Medication (Part I)1
1991
Pharmacokinetic Interactions Between Theophylline and Other Medication (Part II)
1991
Development of a New Controlled-Release Formulation of Chlorpheniramine Maleate Using In Vitro/In Vivo Correlations
1991
Use of a Specific and Sensitive Assay to Determine Pentamidine Pharmacokinetics in Patients with AIDS
1986
Quinidine pharmacokinetics in man: Choice of a disposition model and absolute bioavailability studies
1979
Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide
1984
Simple and Reliable Method for Serial Sampling of Blood from Rats
1975
Gastrointestinal absorption of quinidine from some solutions and commercial tablets
1980
Absorption and disposition of two combination formulations of hydrochlorothiazide and triamterene: Influence of age and renal function
1986
Effects of probenecid on ketoprofen kinetics
1982
Digital cutaneous fluorometry: Correlation between blood flow and fluorescence
1984
Ketoprofen-aspirin interactions
1981
Convenient and sensitive high-performance liquid chromatography assay for ketoprofen, naproxen and other allied drugs in plasma or urine
1980
Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine
1980
Digital cutaneous fluorometry: Correlation between blood flow and fluorescence
1984
Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay
1981
PHARMACOKINETICS OF ORG NC45 (NORCURON) IN PATIENTS WITH AND WITHOUT RENAL FAILURE
1981
Naproxen disposition in patients with alcoholic cirrhosis
1984
Pharmacokinetic Drug Interactions with Theophylline
1984
Renal and Biliary Elimination of Vecuronium (ORG NC 45) and Pancuronium in Rats
1982